Agios Pharmaceuticals, Inc.
AGIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001439222
In the last 90 days, Agios Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 2 sales; 238 institutions reported holding it in 13F filings for Q2 2026, worth $2.45B in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Agios Pharmaceuticals, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 238
- +6 vs. Q1 2026
- Shares held
- 66.0M
- +2.95M (+4.7%) vs. Q1 2026
- Total value
- $2.45B
- +$331.9M (+15.7%) vs. Q1 2026
- New holders
- 38
- 97 more added
- Sold out
- 32
- 66 more reduced
2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting AGIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 238 | $2.45B |
| Q1 2026 | 234 | $2.12B |
| Q4 2025 | 238 | $1.67B |
| Q3 2025 | 221 | $2.55B |
| Q2 2025 | 216 | $2.05B |
| Q1 2025 | 221 | $1.76B |
| Q4 2024 | 225 | $1.97B |
| Q3 2024 | 208 | $2.58B |
| Q2 2024 | 206 | $2.51B |
| Q1 2024 | 187 | $1.81B |
| Q4 2023 | 170 | $1.33B |
| Q3 2023 | 146 | $1.46B |
| Q2 2023 | 153 | $1.68B |
| Q1 2023 | 165 | $1.36B |
| Q4 2022 | 160 | $1.67B |
| Q3 2022 | 168 | $1.64B |
| Q2 2022 | 157 | $1.31B |
| Q1 2022 | 161 | $1.74B |
| Q4 2021 | 161 | $1.95B |
| Q3 2021 | 165 | $2.81B |
| Q2 2021 | 186 | $3.63B |
| Q1 2021 | 175 | $3.37B |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Agios Pharmaceuticals, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Legal & General Group Plc | 434,719 | $16.1M | 0.00% | +10,804+2.5% | Added |
| Jane Street Group, LLC | 492,598 | $18.3M | 0.01% | −192,642−28.1% | Reduced |
| Point72 Asset Management, L.P. | 506,344 | $18.8M | 0.03% | +506,344 | New |
| Bank of America Corp | 507,869 | $18.8M | 0.00% | −310.0% | Reduced |
| Schonfeld Strategic Advisors LLC | 520,083 | $19.3M | 0.10% | +320,022+160.0% | Added |
| Rock Springs Capital Management LP | 532,563 | $19.8M | 0.96% | −266,600−33.4% | Reduced |
| Two Sigma Investments, LP | 536,380 | $19.9M | 0.01% | +284,744+113.2% | Added |
| Charles Schwab Investment Management Inc | 538,128 | $20.0M | 0.00% | +61,096+12.8% | Added |
| Defilade Capital Management, L.P. | 546,848 | $20.3M | 2.72% | +546,848 | New |
| Northern Trust Corp | 554,709 | $20.6M | 0.00% | +45,437+8.9% | Added |
| Qube Research & Technologies Ltd | 597,638 | $22.2M | 0.02% | +409,971+218.5% | Added |
| SCS Capital Management LLC | 612,850 | $22.7M | 0.21% | 00.0% | Unchanged |
| Parkman Healthcare Partners LLC | 669,046 | $24.8M | 2.55% | +265,521+65.8% | Added |
| AQR Capital Management LLC | 684,340 | $25.4M | 0.01% | +647,930+1,779.5% | Added |
| Citadel Advisors LLC | 732,687 | $27.2M | 0.02% | +113,074+18.2% | Added |
| Foresite Capital Management VI LLC | 785,000 | $29.1M | 4.53% | +260,000+49.5% | Added |
| Arrowstreet Capital, Limited Partnership | 810,530 | $30.1M | 0.01% | +560,069+223.6% | Added |
| Nuveen, LLC | 873,560 | $32.4M | 0.01% | +151,212+20.9% | Added |
| Morgan Stanley | 963,256 | $35.7M | 0.00% | −4,269−0.4% | Reduced |
| UBS Group AG | 985,831 | $36.6M | 0.01% | +853,291+643.8% | Added |
| Goldman Sachs Group Inc | 1,150,932 | $42.7M | 0.00% | +345,156+42.8% | Added |
| GW&K Investment Management, LLC | 1,206,615 | $44.8M | 0.35% | −8,286−0.7% | Reduced |
| Dimensional Fund Advisors LP | 1,248,738 | $46.3M | 0.01% | +97,124+8.4% | Added |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 1,280,044 | $47.5M | 0.05% | −300,796−19.0% | Reduced |
| ADAR1 Capital Management, LLC | 1,288,053 | $47.8M | 2.25% | +1,147,381+815.6% | Added |
| Susquehanna International Group, LLP | 1,375,558 | $51.0M | 0.05% | +30,605+2.3% | Added |
| Geode Capital Management, LLC | 1,574,268 | $58.4M | 0.00% | +106,358+7.2% | Added |
| Nomura Asset Management International Inc. | 2,110,809 | $78.3M | 0.12% | +616,374+41.2% | Added |
| Erste Asset Management GmbH | 2,154,900 | $82.0M | 0.64% | −550,000−20.3% | Reduced |
| Armistice Capital, LLC | 2,400,000 | $89.1M | 2.46% | −316,000−11.6% | Reduced |
| Vanguard Capital Management LLC | 2,681,845 | $99.5M | 0.00% | +49,529+1.9% | Added |
| Vanguard Portfolio Management LLC | 2,898,197 | $107.6M | 0.00% | +287,162+11.0% | Added |
| D. E. Shaw & Co., Inc. | 3,107,005 | $115.3M | 0.07% | +425,836+15.9% | Added |
| Lynx1 Capital Management LP | 3,408,937 | $126.5M | 14.62% | +797,369+30.5% | Added |
| State Street Corp | 3,533,633 | $131.1M | 0.00% | +168,754+5.0% | Added |
| Farallon Capital Management, L.L.C. | 5,917,400 | $219.6M | 1.29% | +233,400+4.1% | Added |
| BlackRock, Inc. | 6,455,997 | $239.6M | 0.00% | +701,040+12.2% | Added |
| Coppell Advisory Solutions LLC | 59 | – | – | +59 | New |
| T. Rowe Price Investment Management, Inc. | 0 | $0 | 0.00% | −1,488,740−100.0% | Sold out |
| MPM Oncology Impact Management LP | 0 | $0 | 0.00% | −1,306,261−100.0% | Sold out |
| Frazier Life Sciences Management, L.P. | 0 | $0 | 0.00% | −1,256,080−100.0% | Sold out |
| Artisan Partners Limited Partnership | 0 | $0 | 0.00% | −481,516−100.0% | Sold out |
| Vestal Point Capital, LP | 0 | $0 | 0.00% | −450,000−100.0% | Sold out |
| Eversept Partners, LP | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Essex Investment Management Co LLC | 0 | $0 | 0.00% | −103,177−100.0% | Sold out |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −74,423−100.0% | Sold out |
| Capital International Investors | 0 | $0 | 0.00% | −48,616−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −37,462−100.0% | Sold out |
| Legato Capital Management LLC | 0 | $0 | 0.00% | −32,373−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −32,144−100.0% | Sold out |
| Prelude Capital Management, LLC | 0 | $0 | 0.00% | −29,085−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −21,392−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −18,009−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −16,222−100.0% | Sold out |
| PSP Research LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −13,866−100.0% | Sold out |
| Pale Fire Capital SE | 0 | $0 | 0.00% | −13,650−100.0% | Sold out |
| Voleon Capital Management LP | 0 | $0 | 0.00% | −9,679−100.0% | Sold out |
| Nomura Holdings Inc | 0 | $0 | 0.00% | −9,176−100.0% | Sold out |
| Ground Swell Capital, LLC | 0 | $0 | 0.00% | −8,347−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −8,287−100.0% | Sold out |
| Magnetar Financial LLC | 0 | $0 | 0.00% | −5,936−100.0% | Sold out |
| Clear Street Markets LLC | 0 | $0 | 0.00% | −408−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −350−100.0% | Sold out |
| Optiver Holding B.V. | 0 | $0 | 0.00% | −108−100.0% | Sold out |
| Root Financial Partners, LLC | 0 | $0 | 0.00% | −44−100.0% | Sold out |
| MAI Capital Management | 0 | $0 | 0.00% | −37−100.0% | Sold out |
| Raffa Wealth Management, LLC | 0 | $0 | 0.00% | −32−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| Janus Henderson Group PLC | – | – | – | – | Not filed |
| CWM, LLC | – | – | – | – | Not filed |